Patrick Hayes

AcademicCME Podcast

Health EN ↓ 66 episodes

Enjoy Jointly Accredited Continuing Medical Education podcasts developed by AcademicCME in several advancing disease states. These programs are developed to bring the practicing clinician current with the latest science and provide optimal strategies on applying this science to practice

Author

Patrick Hayes

Episodes

Novel B-Cell Depleting Targeted Therapies to Improve Outcomes in Patients With Sjögren’s Disease 09.06.2026 21:09

This activity was supported by an educational grant from Novartis. Please go to ⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠ https://academiccme.com/courses/CCRSjDPod/ and complete the evaluation to receive your CE/CME Credit. Credit is available through June 7, 2027

Improving Management of Difficult-to-Control Hypertension in Primary Care 01.06.2026 40:47

This activity was supported by an educational grant from AstraZeneca Please go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Link⁠⁠⁠⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through March 15, 2027.

Migliorare la gestione dell'ipertensione difficilmente controllabile nell'assistenza primaria 01.06.2026 48:12

Questa attività è stata sostenuta da un contributo formativo di AstraZeneca. Si prega di visitare il Link e completare la valutazione per ricevere i crediti CE/CME. I crediti sono disponibili fino al 15 marzo 2027.

Verbesserung des Managements schwer einstellbarer Hypertonie in der Primärversorgung 01.06.2026 30:29

Diese Veranstaltung wurde durch ein Bildungsstipendium von AstraZeneca unterstützt. Bitte rufen Sie den Link auf und füllen Sie die Evaluierung aus, um Ihre CE/CME-Punkte zu erhalten. Die Punkte sind bis zum 15. März 2027 verfügbar.

Melhoria do manejo da hipertensão de difícil controle na Atenção Primária 01.06.2026 52:42

Esta atividade foi apoiada por um subsídio educacional da AstraZeneca. Por favor, acesse o Link e preencha a avaliação para receber seus créditos de Educação Continuada (CE/CME). Os créditos estarão disponíveis até 15 de março de 2027.

Beyond Factor Xa: FXI/XIa Inhibition and the Next Era of Stroke Prevention in Atrial Fibrillation 20.05.2026 1:20:06

This activity was supported by an educational grant from the Bristol Myers Squibb and Johnson & Johnson Alliance. Please go to ⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠ http://academiccme.com/HRSPod26 and complete the evaluation to receive your CE/CME Credit. Credit is available through May 6, 2027.

プライマリ・ケアにおける難治性高血圧管理の改善 05.05.2026 36:32

本活動は、アストラゼネカ社からの教育助成により支援されました。CE/CME単位を取得するには、 ACADEMICCME ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠にアクセスし、評価を完了してください。単位の取得は、2027年3月15日まで可能です。Hon katsudō wa, asutorazeneka-sha kara no kyōiku josei ni yori shien sa remashita. CE/ CME tan'i o shutoku suru ni wa, ACADEMICCME ni akusesu shi, hyōka o kanryō shite kudasai. Tan'i no shutoku wa, 202...

Mejora del manejo de la hipertensión de difícil control en Atención primaria 05.05.2026 43:12

Esta actividad contó con el apoyo de una subvención educativa de AstraZeneca. Por favor, acceda al enlace y complete la evaluación para recibir su crédito de educación continua (CE/CME). Los créditos estarán disponibles hasta el 15 de marzo de 2027.

Updating the Efficacy and Safety Experience of IL-17 Inhibitors 22.01.2026 40:00

This activity was supported by an educational grant from UCB Please go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ https://academiccme.com/courses/il17pod/ and complete the evaluation to receive your CE/CME Credit. Credit is available through December 14, 2026.

Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Therapies 11.12.2025 54:38

This activity was supported by an educational grant from Amgen. Please go to ⁠ academiccme.com/lipidpod25 and complete the evaluation to receive your CE/CME Credit. Credit is available through November 25, 2026.

Update on Long-Acting Nebulized Bronchodilators for Guidance-Based Maintenance for Patients with COPD 11.12.2025 32:56

This activity was supported by an educational grant from Viatris Specialty LLC. Please go to ⁠ ⁠ academiccme.com/epccopdpod2 ⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through September 29, 2026.

Therapeutic Update on COPD with Type 2 Inflammation 25.11.2025 26:21

This activity was supported by an educational grant from GSK. Please go to academiccme.com/epccopd1pod and complete the evaluation to receive your CE/CME Credit. Credit is available through September 29, 2026.

Updates on FcRn Blockers for Patients With Myasthenia Gravis: Personalized Treatment Strategies and Shared Decision Making 24.11.2025 1:03:18

This activity was supported by an educational grant from argenx. Credit is available through May 4, 2026.

AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis 17.11.2025 52:08

This activity was supported by an educational grant from Vor Bio. Please go to⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠ ⁠⁠⁠ http://academiccme.com/MG-AANEM-25 and complete the evaluation to receive your CE/CME Credit. Credit is available through November 4, 2026.

ESC 2025: Conference Review and Analysis of Relevant Data Pertaining to LDL-C Lowering 17.11.2025 30:24

This activity was supported by an educational grant from Merck & Co., Inc. Please go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ https://academiccme.com/front-matter/esc25-2/ ⁠⁠⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through October 20, 2026.

Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE) 28.10.2025 1:13:27

This activity was supported by an educational grant from Bristol Myers Squibb. Please go to ⁠ academiccme.com/ccrwestsle ⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.

Clinical Update on Non-Cystic Fibrosis Bronchiectasis: Strategies to Manage Exacerbations and Lung Function 28.10.2025 25:58

This activity was supported by an educational grant from Insmed. Please go to ⁠ https://academiccme.com/epcncfbepod/⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through September 7, 2026.

Conference Review and Analysis of Relevant Data Pertaining to LDL-C 28.10.2025 30:24

This activity was supported by an educational grant from Merck & Co., Inc. Please go to ⁠ ⁠⁠⁠⁠⁠ ⁠⁠https://academiccme.com/front-matter/esc25-1/⁠⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through August 20, 2026.

Foundational Review of Standards of Care for At-Risk Patients with Dyslipidemia 21.08.2025 52:12

This activity was supported by an educational grant from Merck & Co., Inc. Please go to ⁠ ⁠⁠⁠ ⁠https://academiccme.com/front-matter/esc25-1/⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through August 20, 2026.

Review of McDonald Criteria 2024 Updates for the Management of Patients with Multiple Sclerosis 31.07.2025 25:09

This activity was supported by an educational grant from EMD Serono. Please go to ⁠ ⁠ academiccme.com/McDonaldPod and complete the evaluation to receive your CE/CME Credit. Credit is available through October 23, 2025.

Implications of Obstructive Hypertrophic Cardiomyopathy (oHCM) for Heart Failure Specialists 18.07.2025 40:12

This activity was supported by an educational grant from Bristol Myers Squibb. Please go to ⁠ academiccme.com/HFPod and complete the evaluation to receive your CE/CME Credit. Credit is available through May 15, 2026.

ACC 2025 Conference Review and Analysis: Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) 16.07.2025 49:24

This activity was supported by an educational grant from Alnylam Pharmaceuticals. Please go to ⁠ http://academiccme.com/ATTRPod and complete the evaluation to receive your CE/CME Credit. Credit is available through June 25, 2026.

Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiology, and Clinical Trial Analysis of Newer Therapies 17.03.2025 36:38

This activity was supported by an educational grant from Insmed. Please go to academiccme.com/EPCNCFBE and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.

The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH 17.03.2025 38:09

This activity was supported by an educational grant from Merck & Co., Inc.. Please go to ⁠ academiccme.com/EPCPAH and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.

Clinical Strategies for Newer Maintenance Therapies to Reduce Exacerbations in Patients with COPD 03.12.2024 29:06

This activity was supported by an educational grant from Mylan Specialty L.P., a Viatris Company. Please go to ⁠ academiccme.com/front-matter/copd-podcast/ and complete the evaluation to receive your CE/CME Credit. Credit is available through December 2, 2025.